Acute Severe Gastrointestinal Tract Bleeding Is Associated With an Increased Risk of Thromboembolism and Death

Clinical Gastroenterology and Hepatology

Volumn 15, Issue 12, 2017, Pages 1882-1889.e1

  Nagata, Naoyoshi ^a   Sakurai, Toshiyuki ^a   Shimbo, Takuro ^b   Moriyasu, Shiori ^a   Okubo, Hidetaka ^a   Watanabe, Kazuhiro ^a   Yokoi, Chizu ^a   Yanase, Mikio ^a   Akiyama, Junichi ^a   Uemura, Naomi ^c  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b OHTA NISHINOUCHI HOSPITAL   (Japan)

^c National Center for Global Health and Medicine   (Japan)

Author keywords

Lower Gastrointestinal Hemorrhage; Myocardial Infarction; Stroke; Upper Gastrointestinal Hemorrhage

Indexed keywords

ADULT; AGE; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; ENDOSCOPY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GENDER; HIGH RISK PATIENT; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; POPULATION RESEARCH; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOEMBOLISM; AGED; COMPLICATION; MIDDLE AGED; MORTALITY; RISK ASSESSMENT; SURVIVAL ANALYSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; THROMBOEMBOLISM;

EID: 85029232351     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2017.06.028     Document Type: Article

References (21)

1. Staerk, L., Lip, G.Y., Olesen, J.B., et al. Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. Br Med J (Clin Res Ed), 351, 2015, h5876.
2. Nikolsky, E., Stone, G.W., Kirtane, A.J., et al. Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol 54 (2009), 1293–1302.
3. Berger, P.B., Bhatt, D.L., Fuster, V., et al. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Circulation 121 (2010), 2575–2583.
4. O'Donnell, M.J., Kapral, M.K., Fang, J., et al. Gastrointestinal bleeding after acute ischemic stroke. Neurology 71 (2008), 650–655.
5. van Hattum, E.S., Algra, A., Lawson, J.A., et al. Bleeding increases the risk of ischemic events in patients with peripheral arterial disease. Circulation 120 (2009), 1569–1576.
6. Lanas, A., Carrera-Lasfuentes, P., Arguedas, Y., et al. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. Clin Gastroenterol Hepatol 13 (2015), 906–912.
7. Nagata, N., Niikura, R., Sekine, K., et al. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study. J Gastroenterol Hepatol 30 (2015), 292–298.
8. Nagata, N., Niikura, R., Aoki, T., et al. Lower GI bleeding risk of nonsteroidal anti-inflammatory drugs and antiplatelet drug use alone and the effect of combined therapy. Gastrointest Endosc 80 (2014), 1124–1131.
9. Henriksson, A.E., Nilsson, T.K., Svensson, J.O., Hypercoagulability in acute bleeding peptic ulcer disease assessed by thrombin-antithrombin III concentrations. Eur J Surg 159 (1993), 167–169.
10. Velayos, F.S., Williamson, A., Sousa, K.H., et al. Early predictors of severe lower gastrointestinal bleeding and adverse outcomes: a prospective study. Clin Gastroenterol Hepatol 2 (2004), 485–490.
11. Fujino, Y., Inoue, Y., Onodera, M., et al. Risk factors for early re-bleeding and associated hospitalisation in patients with colonic diverticular bleeding. Colorectal Dis 15 (2013), 982–986.
12. Charlson, M.E., Pompei, P., Ales, K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987), 373–383.
13. Aoki, T., Nagata, N., Niikura, R., et al. Recurrence and mortality among patients hospitalized for acute lower gastrointestinal bleeding. Clin Gastroenterol Hepatol 13 (2015), 488–494.
14. Chan, F.K., Leung Ki, E.L., Wong, G.L., et al. Risks of bleeding recurrence and cardiovascular events with continued aspirin use after lower gastrointestinal hemorrhage. Gastroenterology 151 (2016), 271–277.
15. Fine, J., Gray, R., A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94 (1999), 496–509.
16. Vital Statistics of Japan, 2014, Statistics and Information Department, Minister's Secretariat, Ministry of Health and Welfare, Tokyo, Japan Available at: http://www.mhlw.go.jp/english/database/db-hw/.
17. Adams, R.L., Bird, R.J., Review article: Coagulation cascade and therapeutics update: relevance to nephrology. Part 1: overview of coagulation, thrombophilias and history of anticoagulants. Nephrology 14 (2009), 462–470.
18. McMichael, M., New models of hemostasis. Top Companion Anim Med 27 (2012), 40–45.
19. Most, A.S., Ruocco, N.A. Jr., Gewirtz, H., Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis. Circulation 74 (1986), 1085–1092.
20. Sengupta, N., Feuerstein, J.D., Patwardhan, V.R., et al. The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study. Am J Gastroenterol 110 (2015), 328–335.
21. Witt, D.M., Delate, T., Garcia, D.A., et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med 172 (2012), 1484–1491.